CD40LG and systemic lupus erythematosus: Dapirolizumab pegol is a PEGylated anti-CD40L antibody fragment that blocks CD40-CD40L interactions, which are key pathways in T cell-dependent B cell responses and in autoimmune inflammation in SLE.